News Headlines Article

Pradaxa bests warfarin for atrial fibrillation stroke risk
USA Today

The drug Pradaxa has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation. The drug may prove a new option for patients who now use standard blood thinners such as warfarin to control the heart condition.

More than 2 million Americans have atrial fibrillation, which occurs when the heart’s two upper chambers beat quickly and out of sync, the FDA said Wednesday in a news release.

Commands